Tumor lysis syndrome after treatment with docetaxel for non-small-cell lung cancer.
Ajzensztejn
Daniel
D
Department of Oncology, The Whittington Hospital NHS Trust, London, United Kingdom.
Hegde
Vinayak S
VS
Lee
Siow Ming
SM
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000473:pathology; D000368:Aged; D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects*; D000077143:Docetaxel; D017809:Fatal Outcome; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D009362:Neoplasm Metastasis; D043823:Taxoids / Q000009:adverse effects*; D047368:Tumor Burden; D015275:Tumor Lysis Syndrome / Q000209:etiology*
D000972:Antineoplastic Agents, Phytogenic; D043823:Taxoids; D000077143:Docetaxel